Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Veraart CP"'
Publikováno v:
In Value in Health October 2018 21 Supplement 3:S323-S324
Publikováno v:
International Journal of Technology Assessment in Health Care; Oct2008, Vol. 24 Issue 4, p495-501, 7p
Autor:
Brunenberg DE; Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, Maastricht, The Netherlands, UK. dbru@kemta.azm.nl, Joore MA, Veraart CP, Berghmans BC, van der Vaart CH, Severens JL
Publikováno v:
Clinical therapeutics [Clin Ther] 2006 Apr; Vol. 28 (4), pp. 604-18.
Autor:
Breekveldt-Postma NS; PHARMO Institute, Institute for Pharmacology and Outcomes Research, Utrecht, The Netherlands. PHARMO@PHARMO.NL, Schillevoort I, Nolen WA, Veraart CP, Herings RM
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2005 Jan; Vol. 14 (1), pp. 25-30.
Autor:
Hakkaart-van Roijen L; Institute for Medical Technology Assessment, Erasmus Medical Centre, Rotterdam, The Netherlands. hakkaart@bmg.eur.nl, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, Rutten FF
Publikováno v:
Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2004 Nov; Vol. 110 (5), pp. 383-92.
Autor:
van Gestel A; Research Associate, PharMerit BV, Capelle aan den IJssel, The Netherlands. avangestel@pharmerit.com, Bakker J, Veraart CP, van Hout BA
Publikováno v:
Critical care (London, England) [Crit Care] 2004 Aug; Vol. 8 (4), pp. R153-62. Date of Electronic Publication: 2004 May 14.
Autor:
van der Kooij A; Department of Experimental Zoology, Universiteit Utrecht, Padualaan 8, 3584 CH Utrecht, The Netherlands., Veraart CP, van Loon AE
Publikováno v:
Development genes and evolution [Dev Genes Evol] 1998 Feb; Vol. 207 (8), pp. 524-34.